FEV1, % predicted, n (%) | placebo (n = 1524) | SAL (n = 1521) | FP (n = 1534) | SFC (n = 1533) | total (n = 6112) |
---|---|---|---|---|---|
< 30% | 214 (14) | 260 (17) | 220 (14) | 243 (16) | 937 (15) |
30% to < 50% | 775 (51) | 739 (49) | 777 (51) | 728 (47) | 3019 (49) |
50% to < 60% | 347 (23) | 335 (22) | 329 (21) | 349 (23) | 1360 (22) |
60% to < 70% | 148 (10) | 160 (11) | 165 (11) | 173 (11) | 646 (11) |
70% to < 80% | 35 (2) | 25 (2) | 34 (2) | 28 (2) | 122 (2) |
≥ 80% | 5 (< 1) | 2 (< 1) | 9 (< 1) | 12 (< 1) | 28 (< 1) |